| Literature DB >> 26378939 |
Maren Schmidt1, Rahel Eckardt2, Kathrin Scholtz1, Bruno Neuner1, Vera von Dossow-Hanfstingl3, Jalid Sehouli4, Christian G Stief5, Klaus-Dieter Wernecke6, Claudia D Spies1.
Abstract
PURPOSE: This randomized controlled, clinical prospective interventional trial was aimed at exploring the effect of patient empowerment on short- and long-term outcomes after major oncologic surgery in elderly cancer patients.Entities:
Mesh:
Year: 2015 PMID: 26378939 PMCID: PMC4574984 DOI: 10.1371/journal.pone.0137824
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Study flow diagram.
Demographic and clinical baseline characteristics of the study population.
| Intervention | No Intervention | P | |
|---|---|---|---|
| N = 326 | N = 326 | ||
| Mean Age (SD) | 71.6 (4.6) | 72 (5.1) | 0.50 |
| Male (%) | 216 (66.3%) | 231 (70.9%) | 0.24 |
| BMI, mean (SD) | 26 (4.2) | 26 (3.6) | 0.49 |
|
| |||
| Genito-urinary | 226 (69.3%) | 221 (67.8%) | 0.74 |
| Abdomino-thoracic | 100 (30.7%) | 105 (32.2%) | |
| Recurrence of cancer | 47 (14.4%) | 44 (13.5%) | 0.82 |
|
| |||
| Moderate | 9 (2.8%) | 9 (2.8%) | 0.97 |
| Major | 183 (56.1%) | 186 (57.1%) | |
| Major+ | 134 (41.1%) | 131 (40.2%) | |
| Pre-operative Chemotherapy | 40 (12.3%) | 34 (10.4%) | 0.54 |
| Pre-operative Radiotherapy | 11 (3.4%) | 16 (4.9%) | 0.43 |
| ASA I/II | 219 (67.2%) | 206 (63.2%) | 0.32 |
| ASA III/IV | 107 (32.8%) | 120 (36.8%) | |
|
| |||
| 0 | 315 (96.6%) | 311 (95.4%) | 0.65 |
| 1 | 8 (2.5%) | 12 (3.7%) | |
| 2/3 | 3 (0.9%) | 3 (0.9%) | |
| Comorbidities | 2 (2; 4) | 2 (2; 4) | 0.42 |
|
| |||
| Normal | 222 (70.9%) | 230 (72.8%) | 0.84 |
| Risk for malnutrition | 83 (26.5%) | 77 (24.4%) | |
| Malnourished | 8 (2.6%) | 9 (2.8%) | |
|
| |||
| Women | 23.3 (5.3) | 23.1 (5.6) | 0.83 |
| Men | 39.2 (8.5) | 38.9 (8.5) | 0.92 |
| Living alone at home | 64(20.8%) | 62 (20.5%) | >0.99 |
| Living at home with public help | 16 (5.4%) | 11 (3.7%) | 0.33 |
|
| |||
| >High school degree | 109 (37.2%) | 100 (33.83%) | 0.39 |
| Surgery: median length [minutes](IQR) | 165 (105; 250) | 170 (105; 260) | 0,42 |
| Anesthesia: median length [minutes](IQR) | 215 (140; 330) | 220 (150; 330) | 0,56 |
SD = Standard deviation, BMI = Body mass index
$POSSUM: Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity, IQR = Interquartile Range, MMSE = Mini Mental State, EORTC = European Organisation of Research and Treatment of Cancer, ASA = American Society of Anesthesiologists, ECOG =: Eastern Cooperative Oncology Group
§ CCS = Charlson Comorbidity Score
& Mini Nutritional Assessment (MNA)/BMI
€: Students’ t-test
#: χ2-Test (Fisher’s Exact test)
⌘: Mann Whitney U-Test
Elements of the pre-operative Comprehensive Geriatric Assessment.
| Intervention | No Intervention | P | |
|---|---|---|---|
| N = 326 | N = 326 | ||
| ADL, Median (IQR) | 100 (100; 100) | 100 (100; 100) | 0.95 |
| ADL < 100 (%) (n = 645) | 58 (18.0%) | 57 (17.7%) | 0.99 |
| IADL, Median (IQR) | 8 (8;8) | 8 (8;8) | 0.81 |
| IADL < 8 (%) | 53 (16.3%) | 54 (16.6%) | 0.95 |
| MMSE, median (IQR) | 29 (28; 30) | 29 (28; 30) | 0.49 |
| MMSE <27 (%) | 28 (8.6%) | 32 (9.8%) | 0.69 |
|
| |||
| Mild fatigue | 136 (47.6%) | 113 (39.1%) | 0.10 |
| Moderate fatigue | 53 (18.5%) | 68 (23.5%) | |
| Severe fatigue | 7 (2.4%) | 14 (4.8%) | |
|
| |||
| No depression | 256 (88.0%) | 265 (89.8%) | 0.51 |
| Risk for /Manifest depression | 35 (12.0%) | 30 (10.2%) | |
|
| |||
| < 10 sec | 231 (74.5%) | 229 (74.1%) | 0.92 |
| 11–20 sec | 64 (20.6%) | 68 (22.0%) | |
| 21–30 sec | 7 (2.3%) | 6 (1.9%) | |
| > 31 sec | 8 (2.6%) | 6 (1.9%) | |
| TUG >10 sec | 79 (25.5%) | 80 (25.9%) | 0.93 |
| TUG >20 sec | 15 (4.8%) | 12 (3.9%) | 0.70 |
|
| |||
| High (≤18 pts.) | 9 (2.9%) | 12 (3.9%) | 0.56 |
| Moderate (19–23 pts.) | 15 (4.8%) | 20 (6.5%) | |
| Low (≥24 pts.) | 287 (92.3%) | 274 (89.5%) | |
ADL = Activities of daily living, IADL = Instrumental activities of daily living, IQR = Interquartile Range, TUG = Timed up and go, BFI = Brief fatigue inventory, GDS = Geriatric Depression Scale, SD = Standard Deviation.
#: χ2-Test (Fisher’s Exact test)
⌘: Mann Whitney U-Test
Fig 2Median postoperative length of in-hospital stay.
(A) The median length of postoperative in-hospital stay was 9 (IQR 7) days in the intervention group and 9 (IQR 9) days in the control group (p = 0.99).
Fig 3Health-related global quality of life after 12 months for intervention and control groups.
HRQoL 12 months after surgery was comparable in intervention and control groups (all patients p = 0.74).
Fig 4Course of HRQoL.
Comparing the baseline and follow-up values for health-related quality of life only for patients who survived and answered the 12 months questionnaire (n = 418), there were neither clinical relevant nor statistical significant differences between baseline and 12 months for HRQoL (intervention women: p = 0.58; men: p = 0.49; control women: p = 0.16; men = 0.29). Compared to age and gender-adjusted reference values for the German population [18], men showed better global health-related quality of life than the reference population with clinical relevance. In contrast, women quoted a lower score of global HRQoL but without clinical relevance.
Fig 5Perioperative complications.
Overall complications occurred in 74% of the patients. There was no difference between intervention and control group (p = 0.79). Major (Clavien Grade III and higher) perioperative complications occurred in 24% of the patients. There was no difference between the groups (p = 0.41).
Short-term postoperative outcomes.
| Surgical outcomes | Intervention | No Intervention | P |
|---|---|---|---|
| N = 326 | N = 326 | ||
| Any complications | 238(73%) | 241 (73.9%) | 0.86 |
| Delirium | 36 (11.0%) | 30 (9.2%) | 0.52 |
| Other neurological complications | 7 (2.1%) | 8 (2.5%) | 1.00 |
| Acute kidney failure, oliguria | 21 (6.4%) | 13 (4.0%) | 0.22 |
| Infections and sepsis | 51 (15.6%) | 46 (14.1%) | 0.66 |
| Cardiopulmonary | 104 (31.9%) | 97 (29.8%) | 0.61 |
| Hemorrhage requiring transfusion | 22 (6.7%) | 8 (2.5%) |
|
| Anemia requiring transfusion | 53 (16.3%) | 46 (14.1%) | 0.45 |
| Anastomotic leakage | 15 (4.6%) | 11 (3.4%) | 0.42 |
| Intestinal obstruction | 7 (2.1%) | 9 (2.8%) | 0.61 |
| Wound rupture abdominal | 16 (4.9%) | 8 (2.5%) | 0.09 |
| Postoperative pain 1st postoperative day (n = 628) | 234 (75.2%) | 261 (82.3%) |
|
| ICU stay | 132 (40.7%) | 124 (38.6%) | 0.63 |
| ICU stay > 1 day | 93 (29.6%) | 89 (28.6%) | 0.79 |
| Return to the OR | 36 (11%) | 39 (12.0%) | 0.81 |
|
| |||
| No depression | 159 (83.2%) | 161 (82.6%) | 0.86 |
| Risk for depression/Manifest depression | 32(16.8%) | 34 (17.4%) | |
OR: operating room, LOS: length of hospital stay, cardiopulmonary: respiratory insufficiency, angina, myocardial infarction, arrhythmia, lung edema, pulmonary embolism; excluded: pneumonia; SD: standard deviation, IQR: interquartile range.
#: χ2-Test
Fig 6Mortality within 30 days and within one year after surgery for intervention and control groups (p = 0.75 and p = 0.19 respectively).
Within 30 days after surgery, 4 patients in the intervention and 3 patients in the control group had died (p = 0.75). One year after surgery, 45 patients in the intervention group compared to 58 patients in the control group had died (p = 0.19).
Fig 7Kaplan Meier Estimation of Survival in intervention and control groups.
Patients were followed up to one year after surgery. After 12 months 103 (15.8%) patients had died. Mortality did not differ between intervention and control groups (log rank p = 0.197).